Requirement of GrgA for Chlamydia infectious progeny production, optimal growth, and efficient plasmid maintenance

Chlamydia, an obligate intracellular bacterial pathogen, has a unique developmental cycle involving the differentiation of invading elementary bodies (EBs) to noninfectious reticulate bodies (RBs), replication of RBs, and redifferentiation of RBs into progeny EBs. Progression of this cycle is regulated by three sigma factors, which direct the RNA polymerase to their respective target gene promoters. We hypothesized that the Chlamydia-specific transcriptional regulator GrgA, previously shown to activate σ66 and σ28, plays an essential role in chlamydial development and growth. To test this hypothesis, we applied a novel genetic tool known as dependence on plasmid-mediated expression (DOPE) to create Chlamydia trachomatis with conditional GrgA-deficiency. We show that GrgA-deficient C. trachomatis RBs have a growth rate that is approximately half of the normal rate and fail to transition into progeny EBs. In addition, GrgA-deficient C. trachomatis fail to maintain its virulence plasmid. Results of RNA-seq analysis indicate that GrgA promotes RB growth by optimizing tRNA synthesis and expression of nutrient-acquisition genes, while it enables RB-to-EB conversion by facilitating the expression of a histone and outer membrane proteins required for EB morphogenesis. GrgA also regulates numerous other late genes required for host cell exit and subsequent EB invasion into host cells. Importantly, GrgA stimulates the expression of σ54, the third and last sigma factor, and its activator AtoC, and thereby indirectly upregulating the expression of σ54-dependent genes. In conclusion, our work demonstrates that GrgA is a master transcriptional regulator in Chlamydia and plays multiple essential roles in chlamydial pathogenicity. IMPORTANCE Hallmarks of the developmental cycle of the obligate intracellular pathogenic bacterium Chlamydia are the primary differentiation of the infectious elementary body (EB) into the proliferative reticulate body (RB) and the secondary differentiation of RBs back into EBs. The mechanisms regulating these transitions remain unclear. In this report, we developed an effective novel strategy termed DOPE that allows for the knockdown of essential genes in Chlamydia. We demonstrate that GrgA, a Chlamydia-specific transcription factor, is essential for the secondary differentiation and optimal growth of RBs. We also show that GrgA, a chromosome-encoded regulatory protein, controls the maintenance of the chlamydial virulence plasmid. Transcriptomic analysis further indicates that GrgA functions as a critical regulator of all three sigma factors that recognize different promoter sets at developmental stages. The DOPE strategy outlined here should provide a valuable tool for future studies examining chlamydial growth, development, and pathogenicity.

[1]  H. Caldwell,et al.  TargeTron Inactivation of Chlamydia trachomatis gseA Results in a Lipopolysaccharide 3-Deoxy-d-Manno-Oct-2-Ulosonic Acid-Deficient Strain That Is Cytotoxic for Cells , 2023, Infection and Immunity.

[2]  S. Ouellette,et al.  Identification of the alternative sigma factor regulons of Chlamydia trachomatis using multiplexed CRISPR interference , 2023, bioRxiv.

[3]  S. Ouellette,et al.  The Periplasmic Tail-Specific Protease, Tsp, Is Essential for Secondary Differentiation in Chlamydia trachomatis , 2023, Journal of bacteriology.

[4]  I. Coppens,et al.  The inclusion membrane protein IncS is critical for initiation of the Chlamydia intracellular developmental cycle , 2022, PLoS pathogens.

[5]  H. Fan,et al.  Robust Heat Shock Response in Chlamydia Lacking a Typical Heat Shock Sigma Factor , 2022, Frontiers in Microbiology.

[6]  K. Hybiske,et al.  A broad-spectrum cloning vector that exists as both an integrated element and a free plasmid in Chlamydia trachomatis , 2021, PloS one.

[7]  R. Carabeo,et al.  Host Cell Amplification of Nutritional Stress Contributes To Persistence in Chlamydia trachomatis , 2021, bioRxiv.

[8]  H. Fan,et al.  Identification of a GrgA-Euo-HrcA Transcriptional Regulatory Network in Chlamydia , 2021, mSystems.

[9]  H. Fan,et al.  GrgA overexpression inhibits Chlamydia trachomatis growth through sigma66-and sigma28-dependent mechanisms. , 2021, Microbial pathogenesis.

[10]  Z. Khismatullina,et al.  Conflict of interest: the authors declare no conflict of interest. , 2021, Journal Biomed.

[11]  P. S. Hefty,et al.  Sigma 54-Regulated Transcription Is Associated with Membrane Reorganization and Type III Secretion Effectors during Conversion to Infectious Forms of Chlamydia trachomatis , 2020, mBio.

[12]  M. Tan,et al.  The Repressor Function of the Chlamydia Late Regulator EUO Is Enhanced by the Plasmid-Encoded Protein Pgp4 , 2020, Journal of bacteriology.

[13]  K. Hybiske,et al.  Development of Transposon Mutagenesis for Chlamydia muridarum , 2019, Journal of bacteriology.

[14]  T. Ferrin,et al.  Clinical Persistence of Chlamydia trachomatis Sexually Transmitted Strains Involves Novel Mutations in the Functional αββα Tetramer of the Tryptophan Synthase Operon , 2019, mBio.

[15]  T. Snider,et al.  Genetic Inactivation of Chlamydia trachomatis Inclusion Membrane Protein CT228 Alters MYPT1 Recruitment, Extrusion Production, and Longevity of Infection , 2018, Front. Cell. Infect. Microbiol..

[16]  H. Fan,et al.  Role for GrgA in Regulation of σ28-Dependent Transcription in the Obligate Intracellular Bacterial Pathogen Chlamydia trachomatis , 2018, Journal of bacteriology.

[17]  A. Subtil,et al.  The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Chlamydia trachomatis Infectivity and Growth , 2018, Front. Cell. Infect. Microbiol..

[18]  N. Thomson,et al.  The Chlamydia muridarum plasmid revisited : new insights into growth kinetics , 2018, Wellcome open research.

[19]  S. Ouellette Feasibility of a Conditional Knockout System for Chlamydia Based on CRISPR Interference , 2018, Front. Cell. Infect. Microbiol..

[20]  Mark Ellisman,et al.  Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis , 2018, Nature Communications.

[21]  G. Zhong,et al.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection , 2017, Infection and Immunity.

[22]  T. Hackstadt,et al.  Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death. , 2017, Cell reports.

[23]  G. Zhong Chlamydial Plasmid-Dependent Pathogenicity. , 2017, Trends in microbiology.

[24]  Ryan M. Baxter,et al.  The Chlamydia trachomatis Inclusion Membrane Protein CpoS Counteracts STING-Mediated Cellular Surveillance and Suicide Programs. , 2017, Cell host & microbe.

[25]  C. Elwell,et al.  Chlamydia cell biology and pathogenesis , 2016, Nature Reviews Microbiology.

[26]  K. A. Fields,et al.  Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis , 2016, mBio.

[27]  A. Bowlin,et al.  Use of aminoglycoside 3′ adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability , 2015, BMC Research Notes.

[28]  M. Tan,et al.  Transcriptional regulation of the Chlamydia heat shock stress response in an intracellular infection , 2015, Molecular microbiology.

[29]  S. Wigneshweraraj,et al.  The Rsb Phosphoregulatory Network Controls Availability of the Primary Sigma Factor in Chlamydia trachomatis and Influences the Kinetics of Growth and Development , 2015, PLoS pathogens.

[30]  Jeffrey R. Barker,et al.  Integrating chemical mutagenesis and whole-genome sequencing as a platform for forward and reverse genetic analysis of Chlamydia. , 2015, Cell host & microbe.

[31]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[32]  M. Tan,et al.  The transcriptional repressor EUO regulates both subsets of Chlamydia late genes , 2014, Molecular microbiology.

[33]  Brian D Sharon,et al.  Bacterial sigma factors: a historical, structural, and genomic perspective. , 2014, Annual review of microbiology.

[34]  Paul Theodor Pyl,et al.  HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[35]  R. Bastidas,et al.  The Chlamydia trachomatis Type III Secretion Chaperone Slc1 Engages Multiple Early Effectors, Including TepP, a Tyrosine-phosphorylated Protein Required for the Recruitment of CrkI-II to Nascent Inclusions and Innate Immune Signaling , 2014, PLoS pathogens.

[36]  D. Fisher,et al.  Site-Specific, Insertional Inactivation of incA in Chlamydia trachomatis Using a Group II Intron , 2013, PloS one.

[37]  D. Rockey,et al.  Conditional Gene Expression in Chlamydia trachomatis Using the Tet System , 2013, PloS one.

[38]  N. Thomson,et al.  Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model , 2013, Pathogens and disease.

[39]  Igor B. Zhulin,et al.  Analysis of Activator and Repressor Functions Reveals the Requirements for Transcriptional Control by LuxR, the Master Regulator of Quorum Sensing in Vibrio harveyi , 2013, mBio.

[40]  T. Hackstadt,et al.  Chlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanisms. , 2013, Cell reports.

[41]  H. Caldwell,et al.  Chlamydia trachomatis Plasmid-Encoded Pgp4 Is a Transcriptional Regulator of Virulence-Associated Genes , 2013, Infection and Immunity.

[42]  H. Fan,et al.  Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of σ66 , 2012, Proceedings of the National Academy of Sciences.

[43]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[44]  G. Zhong,et al.  A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates , 2011, The Journal of experimental medicine.

[45]  R. Skilton,et al.  Development of a Transformation System for Chlamydia trachomatis: Restoration of Glycogen Biosynthesis by Acquisition of a Plasmid Shuttle Vector , 2011, PLoS pathogens.

[46]  B. Sclavi,et al.  DnaA‐ATP acts as a molecular switch to control levels of ribonucleotide reductase expression in Escherichia coli , 2010, Molecular microbiology.

[47]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[48]  R. Valdivia,et al.  Chlamydial Entry Involves TARP Binding of Guanine Nucleotide Exchange Factors , 2008, PLoS pathogens.

[49]  I. Goodhead,et al.  Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. , 2007, Genome research.

[50]  C. Andrews,et al.  Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease1 , 2007, The Journal of Immunology.

[51]  S. Darst,et al.  Sigma and RNA polymerase: an on-again, off-again relationship? , 2005, Molecular cell.

[52]  Yasser M. Abdelrahman,et al.  The chlamydial developmental cycle. , 2005, FEMS microbiology reviews.

[53]  M. A. Pickett,et al.  The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents. , 2005, Microbiology.

[54]  T. Hackstadt,et al.  A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Tan,et al.  σ28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia , 2003, Molecular microbiology.

[56]  G. Zhong,et al.  Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Richard S. Stephens,et al.  Global Stage-Specific Gene Regulation during the Developmental Cycle of Chlamydia trachomatis , 2003, Journal of bacteriology.

[58]  A. Lambowitz,et al.  Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker. , 2003, Nucleic acids research.

[59]  G. Zhong,et al.  Identification of a Chlamydial Protease–Like Activity Factor Responsible for the Degradation of Host Transcription Factors , 2001, The Journal of experimental medicine.

[60]  S. Darst,et al.  Bacterial RNA polymerase. , 2001, Current opinion in structural biology.

[61]  P. Timms,et al.  Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of σ factors , 1999, FEBS letters.

[62]  R. W. Davis,et al.  Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. , 1998, Science.

[63]  T. Hackstadt,et al.  Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy , 1996, Infection and immunity.

[64]  P. Valentin-Hansen,et al.  The cyclic AMP (cAMP)-cAMP receptor protein complex functions both as an activator and as a corepressor at the tsx-p2 promoter of Escherichia coli K-12 , 1991, Journal of bacteriology.

[65]  T. Hackstadt,et al.  Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Ward,et al.  Sulfur-rich proteins of Chlamydia trachomatis: developmentally regulated transcription of polycistronic mRNA from tandem promoters. , 1990, Gene.

[67]  H. Caldwell,et al.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. , 1987, Journal of immunology.

[68]  H. Caldwell,et al.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis , 1981, Infection and immunity.

[69]  Christopher L. Nobles iGUIDE Method for CRISPR Off-Target Detection. , 2021, Methods in molecular biology.

[70]  Jun S. Liu,et al.  Selective promoter recognition by chlamydial sigma28 holoenzyme. , 2006, Journal of bacteriology.

[71]  P. Lund,et al.  Microbial molecular chaperones. , 2001, Advances in microbial physiology.